ATE151776T1 - Cytotoxische und antivirale verbindung - Google Patents

Cytotoxische und antivirale verbindung

Info

Publication number
ATE151776T1
ATE151776T1 AT94300780T AT94300780T ATE151776T1 AT E151776 T1 ATE151776 T1 AT E151776T1 AT 94300780 T AT94300780 T AT 94300780T AT 94300780 T AT94300780 T AT 94300780T AT E151776 T1 ATE151776 T1 AT E151776T1
Authority
AT
Austria
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
AT94300780T
Other languages
English (en)
Inventor
Paul J Schauer
Mark T Hamann
Dolores G Gravalos
De Tres Cantos Poligono
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of ATE151776T1 publication Critical patent/ATE151776T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT94300780T 1993-02-03 1994-02-02 Cytotoxische und antivirale verbindung ATE151776T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
ATE151776T1 true ATE151776T1 (de) 1997-05-15

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94300780T ATE151776T1 (de) 1993-02-03 1994-02-02 Cytotoxische und antivirale verbindung

Country Status (11)

Country Link
EP (1) EP0610078B1 (de)
JP (1) JP3452628B2 (de)
AT (1) ATE151776T1 (de)
AU (1) AU677258B2 (de)
CA (1) CA2114859C (de)
DE (1) DE69402576T2 (de)
DK (1) DK0610078T3 (de)
ES (1) ES2102772T3 (de)
GB (1) GB9302046D0 (de)
GR (1) GR3024028T3 (de)
ZA (1) ZA94748B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
US7473681B2 (en) * 2000-10-31 2009-01-06 Pharma Mar, S.A. Kahalalide F
WO2003033012A1 (en) * 2001-10-19 2003-04-24 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
PT1572726E (pt) * 2002-10-18 2011-02-14 Pharma Mar Sau Composto kahalalide f 4-metil-hexanóico
CA2501089C (en) * 2002-10-18 2012-07-17 Pharma Mar, S.A.U. 4-methylhexanoic kahalaide f compound
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
CA2703720A1 (en) * 2007-10-19 2009-04-23 Albert Einstein College Of Medicine Of Yeshiva University Improved antitumoral treatments
CA2717117A1 (en) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Improved antitumoral treatments
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE83480T1 (de) * 1988-09-05 1993-01-15 Sankyo Co Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
GR3024028T3 (en) 1997-10-31
EP0610078B1 (de) 1997-04-16
CA2114859C (en) 2008-04-15
EP0610078A1 (de) 1994-08-10
DE69402576T2 (de) 1997-10-02
CA2114859A1 (en) 1994-08-04
JPH0770185A (ja) 1995-03-14
DK0610078T3 (da) 1997-10-20
AU677258B2 (en) 1997-04-17
ES2102772T3 (es) 1997-08-01
GB9302046D0 (en) 1993-03-24
ZA94748B (en) 1994-09-29
JP3452628B2 (ja) 2003-09-29
DE69402576D1 (de) 1997-05-22
AU5491194A (en) 1994-08-11

Similar Documents

Publication Publication Date Title
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
FI905983A (fi) Aminosyraderivat.
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
SE8704298D0 (sv) Compounds for use in therapy
TW226375B (de)
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DE69402576D1 (de) Cytotoxische und antivirale Verbindung
CA2152771A1 (en) 7-o-ethers of taxane derivatives
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
IL107321A0 (en) Substituted azetidinones, their preparation and pharmaceutical compositions comprising them
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
EP0551844A3 (de)
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
ITRM920930A1 (it) Impiego del glutatione per la preparazione di composizioni farmaceutiche ad attivita' antivirale.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification